Wrightington, Wigan and Leigh NHS Foundation Trust   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Wigan United Kingdom (2001)

Organization Overview

First Clinical Trial
2010
NCT00973908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Wrightington Hospital, Wigan UK | Wrightington, Wigan and Leigh NHS Foundation Trust

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Diarrhea (Phase 3)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 10